Mayan Gilboa

1.3k total citations
25 papers, 400 citations indexed

About

Mayan Gilboa is a scholar working on Infectious Diseases, Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mayan Gilboa has authored 25 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 6 papers in Health and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mayan Gilboa's work include SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (6 papers) and Vaccine Coverage and Hesitancy (6 papers). Mayan Gilboa is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (6 papers) and Vaccine Coverage and Hesitancy (6 papers). Mayan Gilboa collaborates with scholars based in Israel, United States and Poland. Mayan Gilboa's co-authors include Gili Regev‐Yochay, Yitshak Kreiss, Ella Mendelson, Yaniv Lustig, Sharon Amit, Keren Asraf, Ram Doolman, Victoria Indenbaum, Laurence S. Freedman and Michal Mandelboim and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Nature Immunology.

In The Last Decade

Mayan Gilboa

23 papers receiving 397 citations

Peers

Mayan Gilboa
Hengameh Mojdeganlou Iran
Leigh L. Speicher United States
Jan Van Elslande Belgium
Deepa Vasireddy United States
Yotam Shenhar Israel
Amirata Fakhfouri Iran
Paavani Atluri United States
Asad Zaidi United Kingdom
Ali Nizar Latif Qatar
Thiago Cerqueira‐Silva Brazil
Hengameh Mojdeganlou Iran
Mayan Gilboa
Citations per year, relative to Mayan Gilboa Mayan Gilboa (= 1×) peers Hengameh Mojdeganlou

Countries citing papers authored by Mayan Gilboa

Since Specialization
Citations

This map shows the geographic impact of Mayan Gilboa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayan Gilboa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayan Gilboa more than expected).

Fields of papers citing papers by Mayan Gilboa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayan Gilboa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayan Gilboa. The network helps show where Mayan Gilboa may publish in the future.

Co-authorship network of co-authors of Mayan Gilboa

This figure shows the co-authorship network connecting the top 25 collaborators of Mayan Gilboa. A scholar is included among the top collaborators of Mayan Gilboa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayan Gilboa. Mayan Gilboa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilboa, Mayan, Maylis Layan, Gili Joseph, et al.. (2025). Factors Associated With the Transmission of the Delta Severe Acute Respiratory Syndrome Coronavirus 2 Variant in Households: The Israeli COVID-19 Family Study (ICoFS). The Journal of Infectious Diseases. 231(4). e734–e742.
2.
Gilboa, Mayan, Gili Regev‐Yochay, Eyal Meltzer, et al.. (2025). Antibiotic Use and the Risk of Hospital-Onset Clostridioides Difficile Infection. JAMA Network Open. 8(8). e2525252–e2525252.
3.
Pogue, Jason M., Lilian M. Abbo, Ellen G Kline, et al.. (2025). P-1105. Effectiveness of Imipenem-Relebactam for Multidrug-resistant Pseudomonas aeruginosa in Pneumonia and Bloodstream Infections in the United States (MIRAGE). Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations
4.
Joseph, Gili, Ili Margalit, Carmit Rubin, et al.. (2024). Persistence of Long COVID Symptoms Two Years After SARS-CoV-2 Infection: A Prospective Longitudinal Cohort Study. Viruses. 16(12). 1955–1955. 4 indexed citations
5.
6.
Gilboa, Mayan, et al.. (2024). Motivations of Israeli physicians to return, or not, to Israel after their fellowship abroad. Israel Journal of Health Policy Research. 13(1). 65–65. 1 indexed citations
7.
Gilboa, Mayan, Tal Gonen, Noam Barda, et al.. (2023). Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel. JAMA Network Open. 6(5). e2314757–e2314757. 20 indexed citations
8.
Klang, Eyal, et al.. (2023). Advantages and pitfalls in utilizing artificial intelligence for crafting medical examinations: a medical education pilot study with GPT-4. BMC Medical Education. 23(1). 772–772. 43 indexed citations
9.
Gilboa, Mayan, et al.. (2023). Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review. Infectious Diseases and Therapy. 12(9). 2223–2240. 11 indexed citations
10.
Amit, Sharon, Mayan Gilboa, Ilana Tal, et al.. (2023). The Use of Rapid COVID-19 Antigen Test in the Emergency Department as a Decision-Support Tool. Microorganisms. 11(2). 284–284. 1 indexed citations
11.
Layan, Maylis, Mayan Gilboa, Tal Gonen, et al.. (2022). Impact of BNT162b2 Vaccination and Isolation on SARS-CoV-2 Transmission in Israeli Households: An Observational Study. American Journal of Epidemiology. 191(7). 1224–1234. 31 indexed citations
12.
Barda, Noam, Mayan Gilboa, Keren Asraf, et al.. (2022). The Association Between Prebooster Vaccination Antibody Levels and the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Clinical Infectious Diseases. 76(7). 1315–1317. 12 indexed citations
13.
Barda, Noam, Mayan Gilboa, Victoria Indenbaum, et al.. (2022). Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up. Nature Communications. 13(1). 7711–7711. 16 indexed citations
14.
15.
Lustig, Yaniv, Tal Gonen, Mayan Gilboa, et al.. (2022). Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose. Nature Immunology. 23(6). 940–946. 50 indexed citations
16.
Gilboa, Mayan, Gili Regev‐Yochay, Michal Mandelboim, et al.. (2022). Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection. JAMA Network Open. 5(9). e2231778–e2231778. 76 indexed citations
17.
Gilboa, Mayan, Ilana Tal, E G Levin, et al.. (2021). Coronavirus disease 2019 (COVID-19) vaccination uptake among healthcare workers. Infection Control and Hospital Epidemiology. 43(10). 1433–1438. 12 indexed citations
18.
Meltzer, Eyal, Gill Smollan, Amit Huppert, et al.. (2019). Universal screening for Clostridioides difficile in a tertiary hospital: risk factors for carriage and clinical disease. Clinical Microbiology and Infection. 25(9). 1127–1132. 22 indexed citations
19.
Gilboa, Mayan, Gil Bornstein, Ilan Ben‐Zvi, & Chagai Grossman. (2019). Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review. Rheumatology International. 40(4). 663–669. 18 indexed citations
20.
Gilboa, Mayan, et al.. (2019). Anxiolytic treatment but not anxiety itself causes hyponatremia among anxious patients. Medicine. 98(5). e14334–e14334. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hengameh Mojdeganlou Breakdown of academic impact, for papers by Leigh L. Speicher Breakdown of academic impact, for papers by Jan Van Elslande Breakdown of academic impact, for papers by Deepa Vasireddy Breakdown of academic impact, for papers by Yotam Shenhar Breakdown of academic impact, for papers by Amirata Fakhfouri Breakdown of academic impact, for papers by Paavani Atluri Breakdown of academic impact, for papers by Asad Zaidi Breakdown of academic impact, for papers by Ali Nizar Latif Breakdown of academic impact, for papers by Thiago Cerqueira‐Silva
Rankless by CCL
2026